The International Air Transport Association (IATA) has announced that it is in the final development phase of the IATA Travel Pass, a digital health pass that will support the safe reopening of borders.

    Governments are beginning to use testing as a means of limiting the risks of Covid-19 importation when re-opening their borders to travellers without quarantine measures. The IATA Travel Pass will manage and verify the secure flow of necessary testing or vaccine information among governments, airlines, laboratories and travellers.

    IATA is subsequently calling for systematic Covid-19 testing of all international travellers and the information flow infrastructure needed to enable this must support:

    • Governments with the means to verify the authenticity of tests and the identity of those presenting the test certificates.
    • Airlines with the ability to provide accurate information to their passengers on test requirements and verify that a passenger meets the requirements for travel.
    • Laboratories with the means to issue digital certificates to passengers that will be recognised by governments, and;
    • Travellers with accurate information on test requirements, where they can get tested or vaccinated, and the means to securely convey test information to airlines and border authorities.

    “Today borders are double locked. Testing is the first key to enable international travel without quarantine measures. The second key is the global information infrastructure needed to securely manage, share and verify test data matched with traveler identities in compliance with border control requirements. That’s the job of IATA Travel Pass. We are bringing this to market in the coming months to also meet the needs of the various travel bubbles and public health corridors that are starting operation,” said IATA’s  director general and CEO, Alexandre de Juniac.

    IATA says that its travel pass incorporates four open sourced and interoperable modules which can be combined for an end-to-end solution:

    • The global registry of health requirements enables passengers to find accurate information on travel, testing and eventually vaccine requirements for their journey.
    • The global registry of testing and vaccination centres enables passengers to find testing centres and labs at their departure location which meet the standards for testing and vaccination requirements of their destination.
    • The Lab App – enables authorised labs and test centers to securely share test and vaccination certificates with passengers.
    • The contactless travel app enables passengers to create a ‘digital passport’, receive test and vaccination certificates and verify that they are sufficient for their itinerary, and share testing or vaccination certificates with airlines and authorities to facilitate travel. This app can also be used by travellers to manage travel documentation digitally and seamlessly throughout their journey, improving travel experience.

    IATA and International Airlines Group (IAG) have been working together in the development of this solution and have said that it will undertake a trial to demonstrate that this platform combined with Covid-19 testing can reopen international travel and replace quarantine.

    “Our main priority is to get people traveling again safely. In the immediate term that means giving governments confidence that systematic Covid-19 testing can work as a replacement for quarantine requirements. And that will eventually develop into a vaccine program. The IATA Travel Pass is a solution for both. And we have built it using a modular approach based on open source standards to facilitate interoperability.

    “It can be used in combination with other providers or as a standalone end-to-end solution. The most important thing is that it is responsive to industry’s needs while enabling a competitive market,” said IATA’s senior vice-president of airport, passenger, cargo and security, Nick Careen.

    The first cross-border IATA Travel Pass pilot is scheduled for later this year and the launch slated for the first quarter of 2021.